MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 

2019 International Congress

September 22-26, 2019. Nice, France.

View by Title View Sessions
View by Date

Wednesday, September 25, 2019

1:15pm-2:45pm
Changing for a rechargeable neurostimulator in Parkinson’s disease patients: safety and feasibility

T. Wirth, C. Laurencin, J. Berthiller, A. Brindzeu, E. Simon, G. Polo, P. Mertens, E. Broussolle, T. Danaila, S. Thobois (Strasbourg, France)

Surgical Therapy  ·  Les Muses Terrace, Level 3
1:15pm-2:45pm
Characteristics of lower gastrointestinal tract dysfunction in patients with Parkinson disease

T. Uchiyama, T. Yamamoto, K. Suzuki, T. Kadowaki, H. Nakajima, R. Sakakibara, S. Kuwabara, K. Hirata, M. Murai (Chiba, Japan)

Non-Motor Symptoms  ·  Agora 3 West, Level 3
1:15pm-2:45pm
Characteristics of spontaneous brain activity in left- and right-onset Parkinson’s disease patients

K. Li, W. Su, H. Zhao, C. Li, X. Ma, B. Lou, M. Chen, H. Chen (Beijing, China)

Neuroimaging  ·  Les Muses Terrace, Level 3
1:15pm-2:45pm
Characteristics of the clinical and cerebral metabolism in Parkinson’s disease with atrophy in nucleus basalis of Meynert

MY. Gang, T. Baba, Y. Hosokai, Y. Nishio, A. Kikuchi, K. Hirayama, T. Hasegawa, M. Aoki, A. Takeda, E. Mori, K. Suzuki (Sendai, Japan)

Non-Motor Symptoms  ·  Agora 3 West, Level 3
1:15pm-2:45pm
Characterization of the gastrointestinal dysfunction in the 6-hydroxydopamine rat model of Parkinson’s disease

X. Chai, S. Diwakarla, R. Pustovit, R. Mcquade, M. Di Natale, C. Ermine, C. Parish, D. Finkelstein, J. Furness (Melbourne, Australia)

Non-Motor Symptoms  ·  Agora 3 West, Level 3
1:15pm-2:45pm
Characterizing olfactory impairment in patients with Parkinson’s disease and related disorders

Y. Watanabe, K. Suzuki (Mibu, Shimotsuga, Tochigi, Japan)

Non-Motor Symptoms  ·  Agora 3 West, Level 3
1:15pm-2:45pm
Circadian and Homeostatic Modulation of Multi-unit Activity in Dopaminergic and Striatal Structures

K. Fifel, T. Deboer (Leiden, Netherlands)

Non-Motor Symptoms  ·  Agora 3 West, Level 3
1:15pm-2:45pm
Classify Parkinson’s Disease with Mild Cognitive Impairment: Machine Learning Approach

SS. Cho, C. Li, Y. Koshimori, J. Kim, L. Christopher, M. Dı´ez-Cirarda, M. Valli, A. Mihaescu, S. Houle, A. Strafella (Toronto, ON, Canada)

Neuroimaging  ·  Les Muses Terrace, Level 3
1:15pm-2:45pm
Clinical and DAT Imaging Characteristics of Participants with Scans without Evidence of Dopaminergic Deficit (SWEDDs): PPMI Cohort 2 year follow-up

K. Marek, T. Simuni, A. Siderowf, D. Lafontant, C. Caspell-Garcia, C. Coffey, B. Mollenhauer, C. Tanner, K. Kieburtz, L. Chahine, J. Seibyl (New Haven, CT, USA)

Neuroimaging  ·  Les Muses Terrace, Level 3
1:15pm-2:45pm
Clinical and epidemiological data on Parkinson’s disease in older adults: experience of a single Italian centre.

T. Schirinzi, G. Di Lazzaro, M. Pierantozzi, A. Stefani, N. Mercuri, A. Pisani (Rome, Italy)

Epidemiology  ·  Les Muses, Level 3